In the present study, through immunohistochemical experiments, western blot and qRT-PCR, we identified that TRIB3 was highly expressed in ovarian cancer in protein and mRNA level, which was confirmed by expression analysis studies in the Oncomine and GEPAI databases. Here, TRIB3 is linked to ovarian carcinoma.